Atlas Trials

A Safety and Feasibility Study of Mitotane in Prostate Cancer

Clinical trial NCT02057237 · COMPLETED

Trial details

NCT number
NCT02057237
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2013-09-01
Primary completion
2015-04-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.